Massachusetts Financial Services CO Esperion Therapeutics, Inc. Transaction History

Massachusetts Financial Services CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	SELL	$31.18 - $52.71 $1.74 Million - $2.93 Million	-55,649 Closed	0 $0
Q2 2020 Aug 11, 2020	SELL	$30.04 - $51.31 $42,626 - $72,808	-1,419 Reduced 2.49%	55,649 $2.86 Million
Q1 2020 May 14, 2020	BUY	$27.44 - $73.84 $247,838 - $666,922	9,032 Added 18.8%	57,068 $1.8 Million
Q4 2019 Feb 13, 2020	SELL	$35.4 - $59.82 $183,796 - $310,585	-5,192 Reduced 9.75%	48,036 $2.86 Million
Q3 2019 Nov 05, 2019	BUY	$34.47 - $47.53 $1.83 Million - $2.53 Million	53,228 New	53,228 $1.95 Million

207

128M

1.67M

930K

Ticker ESPR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,551,600
Market Cap $168M
Description
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...

Get notified when there are updates to the investment portfolio of Massachusetts Financial Services CO , based on Form 13F filings with the SEC.

Stay updated on Massachusetts Financial Services CO with notifications on news.